We are live on
!
Find out more
GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
1-Year Est. Return
21.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.9%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$447M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow
% of AUM
101.18%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
260
New
260
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 2 |
CELG
Celgene Corp
CELG
|
+$16.3M |
| 3 |
Amgen
AMGN
|
+$12.9M |
| 4 |
Southwest Airlines
LUV
|
+$12.3M |
| 5 |
Apple
AAPL
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.33% |
| 2 | Consumer Staples | 13.46% |
| 3 | Industrials | 12.37% |
| 4 | Energy | 9.97% |
| 5 | Technology | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Regeneron Pharmaceuticals
REGN
$68.8B
| $15.9M | 3.55% |
+70,490
| New | +$16.4M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $15.8M | 3.55% |
+270,840
| New | +$16.3M |
|
|
3
Amgen
AMGN
$203B
| $12.3M | 2.76% |
+124,789
| New | +$12.9M |
|
|
4
Southwest Airlines
LUV
$22.1B
| $11.7M | 2.61% |
+905,282
| New | +$12.3M |
|
5
JPMorgan Chase
JPM
$939B
| $11.1M | 2.48% |
+209,988
| New | +$10.7M |
|
|
6
Apple
AAPL
$4.89T
| $9.99M | 2.24% |
+705,068
| New | +$10.8M |
|
7
GE Aerospace
GE
$367B
| $9.25M | 2.07% |
+83,252
| New | +$9.22M |
|
8
Colgate-Palmolive
CL
$72.6B
| $9.05M | 2.03% |
+157,977
| New | +$9.38M |
|
9
PepsiCo
PEP
$186B
| $9.04M | 2.02% |
+110,541
| New | +$9.03M |
|
10
Johnson & Johnson
JNJ
$635B
| $8.34M | 1.87% |
+97,168
| New | +$8.25M |
|
11
Walmart Inc
WMT
$871B
| $8.25M | 1.85% |
+332,196
| New | +$8.51M |
|
12
IBM
IBM
$202B
| $7.72M | 1.73% |
+42,268
| New | +$8.23M |
|
13
Procter & Gamble
PG
$343B
| $7.46M | 1.67% |
+96,901
| New | +$7.61M |
|
14
Honeywell
HON
$77.1B
| $7.33M | 1.64% |
+102,870
| New | +$7.09M |
|
15
Coca-Cola
KO
$354B
| $6.81M | 1.52% |
+169,711
| New | +$7.03M |
|
16
ExxonMobil
XOM
$651B
| $6.49M | 1.45% |
+71,874
| New | +$6.47M |
|
17
Visa
V
$677B
| $6.34M | 1.42% |
+138,760
| New | +$6.07M |
|
|
SNDK
18
DELISTED
SANDISK CORP
SNDK
| $6.34M | 1.42% |
+103,760
| New | +$5.92M |
|
19
Philip Morris
PM
$301B
| $6.12M | 1.37% |
+70,637
| New | +$6.56M |
|
20
Bristol-Myers Squibb
BMY
$127B
| $5.88M | 1.32% |
+131,631
| New | +$5.71M |
|
21
Intel
INTC
$466B
| $5.81M | 1.3% |
+239,765
| New | +$5.66M |
|
22
Enterprise Products Partners
EPD
$83.8B
| $5.42M | 1.21% |
+174,516
| New | +$5.29M |
|
|
DD
23
DELISTED
Du Pont De Nemours E I
DD
| $5.22M | 1.17% |
+104,786
| New | +$5.29M |
|
24
Bank of America
BAC
$435B
| $5.06M | 1.13% |
+393,604
| New | +$5.02M |
|
25
Citigroup
C
$222B
| $4.99M | 1.12% |
+103,959
| New | +$5M |
|
Similar funds
KRC
GS
PAAMCP
B
JPCCM
NBC
NTC
SD
Gerald L. Ray & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Gerald L. Ray & Associates, which disclosed 260 positions worth $447M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Industrials.
- Gerald L. Ray & Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
- Gerald L. Ray & Associates's ten largest holdings make up 25% of its $447M portfolio in Q2 2013.
- Gerald L. Ray & Associates disclosed 260 positions in Q2 2013, its first 13F filing on record.
Based on Gerald L. Ray & Associates's 13F filing for Q2 2013, filed 1 Aug 2013.